Jobs IRLDecoding DemocracyA Warmer WorldI've Always Wondered ...

Loading...

0:00
0% played
Stories Tagged as

Vaccine trials

COVID-19

Oxford-AstraZeneca vaccine may pose fewer distribution challenges

by David Brancaccio , Victoria Craig and Alex Schroeder
Nov 23, 2020
That would be an advantage particularly for getting a COVID-19 vaccine to developing countries.
An illustration picture shows vials with COVID-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca, on Nov. 17, 2020.
Justin Tallis/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE